
|Articles|February 1, 2006
Demystifying the black box warning on antidepressants: A protocol for safe prescribing in your practice
Don't let the FDA warning about suicidality discourage you from prescribing an antidepressant for the child or adolescent who needs it. These recommendations provide a guide to monitoring patients for suicidal ideation and other adverse effects.
Advertisement
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Environmental distress in children: Recognizing and responding to eco-anxiety
2
FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C
3
Health system–based clinical pathway improves pediatric lipid screening rates
4
AHA issues 2025 CPR and ECC updates for choking, opioid overdose, and pediatric care
5














